期刊
PEDIATRIC DRUGS
卷 19, 期 4, 页码 313-324出版社
ADIS INT LTD
DOI: 10.1007/s40272-017-0231-7
关键词
-
资金
- GlaxoSmithKline
- Novartis
- Pfizer
- Novavax
- MedImmune
- National Health and Medical Research Council Early Career Fellowship [APP1054394]
- MCRI Career Development Award
Maternal immunization has undergone a paradigm shift in recent years, as women and healthcare providers accept and recognize the benefits of this strategy not only for the pregnant woman but also for the developing fetus and young infant. This article reviews the evidence for active immunization during pregnancy, with an emphasis on perinatal and infant outcomes. Current recommendations for immunization during pregnancy are presented, with particular focus on the routinely recommended vaccines during pregnancy: influenza and Tdap (tetanus, diphtheria, and pertussis). We discuss future research directions, maternal vaccines in development, and considerations for optimizing and advancing this underutilized strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据